In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Karyopharm Therapeutics Inc (NASDAQ: KPTI) closed at $0.85 up 1.38% from its previous closing price of $0.84. In other words, the price has increased by $1.38 from its previous closing price. On the day, 0.58 million shares were traded. KPTI stock price reached its highest trading level at $0.8653 during the session, while it also had its lowest trading level at $0.8261.
Ratios:
For a deeper understanding of Karyopharm Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.56 and its Current Ratio is at 3.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on January 19, 2023, initiated with a Overweight rating and assigned the stock a target price of $8.
On November 04, 2022, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform and also upped its target price recommendation from $7 to $10.
JP Morgan Upgraded its Underweight to Neutral on February 09, 2022, while the target price for the stock was maintained at $8.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 04 ’24 when Paulson Richard A. sold 3,607 shares for $0.88 per share. The transaction valued at 3,172 led to the insider holds 1,135,607 shares of the business.
Mano Michael sold 3,971 shares of KPTI for $2,866 on Sep 04 ’24. The SVP, General Counsel&Secretary now owns 273,881 shares after completing the transaction at $0.72 per share. On Sep 04 ’24, another insider, Paulson Richard A., who serves as the President and CEO of the company, sold 3,667 shares for $0.72 each. As a result, the insider received 2,647 and left with 1,139,214 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KPTI now has a Market Capitalization of 106554944 and an Enterprise Value of 223560672. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.73. Its current Enterprise Value per Revenue stands at 1.535 whereas that against EBITDA is -1.712.
Stock Price History:
Over the past 52 weeks, KPTI has reached a high of $1.95, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is 7.44%, while the 200-Day Moving Average is calculated to be -16.31%.
Shares Statistics:
For the past three months, KPTI has traded an average of 770.54K shares per day and 1225540 over the past ten days. A total of 114.92M shares are outstanding, with a floating share count of 114.06M. Insiders hold about 8.52% of the company’s shares, while institutions hold 54.20% stake in the company. Shares short for KPTI as of 1726185600 were 17926868 with a Short Ratio of 23.27, compared to 1723680000 on 18255570. Therefore, it implies a Short% of Shares Outstanding of 17926868 and a Short% of Float of 14.66.
